Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 23, 2026
DataAggregated Company Financials
Companies7
- 7D-1.5%
- 3M-6.0%
- 1Y-37.8%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 4.9%, driven by Oxford Nanopore Technologies declining 5.1%. Meanwhile, Oxford BioDynamics actually outperformed within the industry, gaining 24% in the last week. However, the industry is down 37% over the past year. Looking forward, earnings are forecast to grow by 51% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 23 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1152.2x | -7.8x | 4x |
| Sat, 20 Jun 2026 | UK£1.4b | UK£323.0m | -UK£166,018,254.00 | 1291.9x | -8.2x | 4.2x |
| Mon, 18 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.4x | 4.4x |
| Wed, 15 Apr 2026 | UK£1.3b | UK£323.0m | -UK£156,192,254.00 | 11.2x | -8.5x | 4.1x |
| Fri, 13 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.6x | -8.5x | 4.2x |
| Sun, 08 Feb 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 7.9x | -10x | 5.3x |
| Tue, 06 Jan 2026 | UK£1.5b | UK£304.6m | -UK£159,441,254.00 | 8.4x | -9.2x | 4.8x |
| Thu, 04 Dec 2025 | UK£1.5b | UK£303.9m | -UK£162,910,254.00 | 7.3x | -9.1x | 4.9x |
| Sat, 01 Nov 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.5x | -9.5x | 5.1x |
| Mon, 29 Sep 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 9.9x | -10.2x | 5.5x |
| Wed, 27 Aug 2025 | UK£2.1b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.4x | 7.4x |
| Fri, 25 Jul 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.2x | -13.5x | 7.5x |
| Sun, 22 Jun 2025 | UK£1.5b | UK£319.6m | -UK£191,020,739.20 | 6.5x | -8x | 4.8x |
| Tue, 20 May 2025 | UK£1.6b | UK£313.1m | -UK£192,819,167.00 | 11.5x | -8.3x | 5.1x |
| Thu, 17 Apr 2025 | UK£1.6b | UK£315.0m | -UK£185,758,477.90 | 6.5x | -8.5x | 5x |
| Sat, 15 Mar 2025 | UK£1.5b | UK£315.6m | -UK£186,194,740.85 | 6.3x | -7.9x | 4.7x |
| Mon, 10 Feb 2025 | UK£1.9b | UK£307.1m | -UK£195,645,066.48 | 6.8x | -9.8x | 6.2x |
| Wed, 08 Jan 2025 | UK£1.9b | UK£306.8m | -UK£195,441,371.28 | 7.2x | -9.9x | 6.3x |
| Fri, 06 Dec 2024 | UK£2.1b | UK£306.1m | -UK£194,864,592.24 | 8.3x | -10.5x | 6.7x |
| Sun, 03 Nov 2024 | UK£1.9b | UK£304.8m | -UK£192,652,400.50 | 11x | -9.9x | 6.3x |
| Tue, 01 Oct 2024 | UK£2.1b | UK£303.6m | -UK£191,731,220.50 | 11x | -11.2x | 7x |
| Thu, 29 Aug 2024 | UK£1.8b | UK£295.6m | -UK£188,270,494.80 | 12.3x | -9.6x | 6.1x |
| Sat, 27 Jul 2024 | UK£1.9b | UK£295.4m | -UK£189,801,674.25 | 12.6x | -9.8x | 6.3x |
| Mon, 24 Jun 2024 | UK£1.5b | UK£296.0m | -UK£190,309,224.21 | 11.5x | -7.7x | 5x |
| Wed, 22 May 2024 | UK£1.6b | UK£293.9m | -UK£188,125,665.18 | 8661.9x | -8.4x | 5.4x |
| Fri, 19 Apr 2024 | UK£1.5b | UK£317.8m | -UK£178,601,486.69 | 11.5x | -8.2x | 4.6x |
| Sun, 17 Mar 2024 | UK£1.9b | UK£295.6m | -UK£212,950,708.15 | 7176.9x | -8.8x | 6.3x |
| Tue, 13 Feb 2024 | UK£2.1b | UK£285.9m | -UK£189,304,932.92 | 7107.4x | -11.3x | 7.5x |
| Thu, 11 Jan 2024 | UK£3.0b | UK£449.9m | -UK£173,954,231.00 | 66.7x | -17.3x | 6.7x |
| Sat, 09 Dec 2023 | UK£3.0b | UK£453.0m | -UK£170,828,170.00 | 47.2x | -17.4x | 6.6x |
| Mon, 06 Nov 2023 | UK£3.2b | UK£458.1m | -UK£165,180,912.00 | 47.6x | -19.4x | 7x |
| Wed, 04 Oct 2023 | UK£2.9b | UK£449.1m | -UK£169,444,502.00 | 64.4x | -17.4x | 6.6x |
| Fri, 01 Sep 2023 | UK£3.1b | UK£476.3m | -UK£126,626,444.00 | 70.6x | -24.6x | 6.5x |
| Sun, 30 Jul 2023 | UK£3.4b | UK£476.2m | -UK£124,491,061.00 | 69.6x | -27.3x | 7.1x |
Price to Earnings Ratio
-27.3x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.95% | |
| Healthcare | 0.68% | |
| Life Sciences | -1.52% | |
| Clinical Research and Equipment | -1.52% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OBD Oxford BioDynamics | UK£0.0013 | 23.8% +UK£1.1m | -74.8% | PS4.7x | |
| IXI IXICO | UK£0.085 | 3.0% +UK£545.1k | -19.0% | PS2.5x |
